Jakob Dupont serves as Executive at OncoMed Pharmaceuticals Inc, where they oversee executive responsibilities. Since joining the company, Jakob Dupont has executed 61 insider transactions totaling $2.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 10, 2015 involved exercising options for 1,500 shares valued at $6.8K.
Jakob Dupont currently holds 38,741 shares of OncoMed Pharmaceuticals Inc (OMED), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jakob Dupont has been a net seller of OMED stock. They have purchased $0 and sold $2.1M worth of shares.
Jakob Dupont's most recent insider trade was on Feb 10, 2015, when they sold 1,500 shares at $4.56 per share.
Get notified when new Form 4 filings are submitted
| $26.62 |
| Discretionary |
| Jan 12, 2015 | OMED | $28.2K | Sale | 1,100 | $25.63 | Discretionary |
| Jan 12, 2015 | OMED | $6.8K | Option Exercise | 1,500 | $4.56 | Discretionary |
| Jan 5, 2015 | OMED | $172.5K | Sale | 7,500 | $23.00 | Discretionary |
| Jan 5, 2015 | OMED | $34.2K | Option Exercise | 7,500 | $4.56 | Discretionary |
| Jul 23, 2014 | OMED | $34.5K | Sale | 1,500 | $23.00 | Discretionary |
| Jul 23, 2014 | OMED | $6.8K | Option Exercise | 1,500 | $4.56 | Discretionary |
| Jun 26, 2014 | OMED | $6.8K | Option Exercise | 1,500 | $4.56 | Discretionary |
| Jun 26, 2014 | OMED | $34.5K | Sale | 1,500 | $23.00 | Discretionary |
| Mar 25, 2014 | OMED | $0 | Award | 20,000 | $N/A | Discretionary |